- Filed
- Mar 28, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 26, 2025 | 2.55M sh |
| Shares Diluted | FY 2024 · Dec 31, 2024 | 1.05M sh |
| Shares Diluted restated | FY 2024 · Dec 31, 2023 | 750.38K sh |
| Operating Cash Flow | FY 2024 · Dec 31, 2024 | −$3.95M |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$3.15M |
| Cash And Equivalents | FY 2024 · Dec 31, 2024 | $2.18M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $3.29M |
| Stockholders Equity | FY 2024 · Dec 31, 2024 | $1.92M |
| Stockholders Equity | FY 2024 · Dec 31, 2023 | $3.14M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $4.68M |
| Current Liabilities | FY 2024 · Dec 31, 2024 | $754.42K |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $385.36K |
| Total Liabilities | FY 2024 · Dec 31, 2024 | $754.42K |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $432.73K |
| Current Assets | FY 2024 · Dec 31, 2024 | $2.62M |
| Current Assets | FY 2024 · Dec 31, 2023 | $3.43M |
| Total Assets | FY 2024 · Dec 31, 2024 | $2.67M |
| Total Assets | FY 2024 · Dec 31, 2023 | $3.58M |
| Eps Diluted | FY 2024 · Dec 31, 2024 | −$4.79 |
| Eps Diluted restated | FY 2024 · Dec 31, 2023 | −$6.16 |
| Eps Basic | FY 2024 · Dec 31, 2024 | −$4.79 |
| Eps Basic restated | FY 2024 · Dec 31, 2023 | −$6.16 |
| Sga Expense | FY 2024 · Dec 31, 2024 | $2M |
| Sga Expense | FY 2024 · Dec 31, 2023 | $2.16M |
| Rd Expense | FY 2024 · Dec 31, 2024 | $3.61M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $3.04M |
| Net Income | FY 2024 · Dec 31, 2024 | −$5.02M |
| Net Income | FY 2024 · Dec 31, 2023 | −$4.62M |
| Operating Income | FY 2024 · Dec 31, 2024 | −$5.08M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$4.75M |
| Revenue | FY 2024 · Dec 31, 2024 | $536.36K |
| Revenue | FY 2024 · Dec 31, 2023 | $449.62K |
| Capex | FY 2024 · Dec 31, 2023 | $14.43K |